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Understanding human development is of fundamental biological and clinical 
importance. Yet despite its significance, insights into early developmental events in 
humans still remain largely unknown. While recent advances show that stem cells can 
mimic embryogenesis1-9 to unravel hidden developmental mechanisms, a stem cell-
based model of early human embryogenesis is lacking. Here, we use human extended 
pluripotent stem cells10 to reconstitute early human development in 3-dimensions and 
recapitulate early embryo-like events. We first perform a systematic characterisation to 
reveal unique signalling requirements for building the human pre-implantation 
blastocyst. Further, we show that these in vitro stem cell-derived blastocyst-like 
structures are able to undertake spatiotemporal self-organisation to mimic peri-
implantation remodelling in which a polarised rosette opens up the amniotic cavity 
within a developing disc. The hallmarks of human early development displayed by this 
stem cell-based in vitro model mimics features of embryonic day 3 to day 9/10 of natural 
development. Thus, this platform represents a tractable model system to contribute to 
the basic understanding of cellular and molecular mechanisms governing early 
embryonic events in humans and to provide valuable insights into the design of 
differentiation protocols for human stem cells in clinical applications.  
 
Development begins in the zygote, a single fertilised egg. While the undifferentiated zygote 
holds the potential to form all embryonic and extra-embryonic lineages11,12, cells gradually lose 
potency as they diversify into specialized functional cell types as development progresses. 
During the acquisition of cell fate, cells follow a precise sequence of regulative events, 
governed by distinct mechanisms that maintain a fine balance between pluripotency and 
differentiation. The first cell fate decisions take place after embryonic day 3 (D3) in the human 
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pre-implantation embryo and generate spatially segregated lineages by D5/6, forming an 
organised, hollow structure referred to as the blastocyst (Fig. 1a). The blastocyst initially 
comprises two distinct cell populations: the extra-embryonic trophectoderm (TE), an outer 
epithelium, and the embryonic pluripotent inner cell mass (ICM), positioned to one side of the 
cavity (Fig. 1a). The ICM is considered to represent an initial multi-lineage priming state, which 
undergoes a second differentiation event just prior to implantation at D6-713.  During this event, 
the transient ICM gives rise to both the epiblast (Epi), the source of all foetal cell lineages, and 
the extra-embryonic hypoblast (Hypo) (Fig. 1a). Following implantation, the ICM-derived 
lineages undergo a series of morphological changes leading to the formation of a disc-shape 
structure.  
Recent in vitro culture methods have advanced our abilities to study aspects of natural human 
embryo development ex-utero14-16. These systems, while valuable, have restricted use in 
investigations of the basic biology of early human embryogenesis because of technical and 
ethical limitations that hinder significant progress17. Thus, the development of methods to 
recapitulate the principles of development in vitro with stem cells is gaining momentum leading 
to models that successfully recapitulate various aspects of natural embryogenesis with stem 
cells in mice2-4,7,9,18-22 and human1,23,24. While these platforms provide great potential for 
understanding hidden developmental mechanisms in mammals, an in vitro model that 
recapitulates distinct spatiotemporal events in early human embryogenesis remains lacking.  
Recent studies showed that pluripotent stem cells (PSCs) can be reprogrammed to a 
molecular state similar to that of earlier blastomeres with an enhanced developmental potency 
for both embryonic and extra-embryonic cell lineages, termed extended or expanded 
pluripotency (EP)10,25,26. The impetus to reconstitute the unique development of the early 
human embryo with stem cells in vitro led us to hypothesize that human pluripotent stem cells 
(hPSCs) under conditions of EP should be able to undertake early cell fate decisions and self-
organise into 3-dimentional (3D) embryo-like structures. After conversion of hPSCs to 
hEPSCs over 5 passages (see Materials and Methods), we confirmed that such cells could 
acquire the morphological features characteristic of pluripotent cells in the naïve state of 
pluripotency, including dome-shaped colony formation, as supported by earlier observations10 
(Fig. 1b). It is noteworthy that we could observe flat cell colonies, a morphological feature 
characteristic to pluripotent cells at the primed state, in different ratios after each passage, 
indicating a mixed population of cells at different pluripotent states under EP culture conditions 
(Extended Data Fig. 1a). Using the multi-inverted-pyramid microwell-based 3D culture 
system2,3, we seeded hEPSCs in small numbers (5-6 cells per microwell) to enable their 
aggregation and subsequent self-organisation (Fig. 1c). Importantly, we developed a culture 
media that enabled us to generate cystic structures that capture the multi-potency of hEPSCs 
to generate embryo-like lineages over 4 days of 3D culture (see Materials and Methods). To 
do this, we first observed that the in vitro media normally used for the culture of natural human 
pre-implantation embryos promoted the formation of these cystic structures (Extended Data 
Fig. 1b, see Methods). In order to support the maintenance of pluripotency and to promote 
TE differentiation, we mixed 2 parts of this medium with 1 part of EP10 and 1 part of hTSC27, 
two different stem cell-base media (see Materials and Methods). Moreover, we found that low 
oxygen tension (5% O2) facilitated efficient formation of cavitated structures (Extended Data 
Fig. 1c), similar to our previous observations of mouse blastoid formation from mouse EPSCs3 
and in the development of natural human blastocysts28.  
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We next screened different growth factors, cytokines, and small molecules to identify 
conditions enabling the generation of structures closely resembling human blastocysts with 
both cavity and early-lineage specification (Extended Data Fig. 2a-Ee). We found that a 
combination of BMP4 (20ng/ml), WNT antagonist CHIR99021 (2uM), FGF2 (40ng/ml) and 
ROCK inhibitor Y-27632 (5uM) during the first 48h of 3D culture enhanced cell survival and 
promoted formation of compact cellular aggregates (Extended Data Fig. 2a-f). Additionally, 
we pulsed the cells with ALK5 inhibitor A83-01 (2uM) to promote TE differentiation27 for the 
first 48h of 3D culture. After this initial 48h, A83-01 was omitted from the culture media in order 
to avoid a complete loss in pluripotency. Concomitantly, the concentration of FGF2 was 
decreased by half (20ng/ml) for the same purpose1. Using this optimized condition, we 
consistently observed the emergence of cavitated cystic structures, 3 to 4 days after cell 
seeding (Fig. 1d). By day 6 of 3D culture, the structures exhibited typical blastocyst-like 
morphology, forming a cohesive single outside layer, with an enlarged cavity, and an internal 
acentric compartment (Fig. 1d-e). Importantly, when SOX2:GFP reporter EPSCs29 were used 
to generate these structures, we found that the ICM-like compartment was positive for GFP 
signal, while TE-like outer cells were negative (Fig. 1f). We also detected KRT18 expression 
in the outer layer, confirming correct lineage specification and resemblance to natural 
blastocysts13 (Fig. 1G). The average cell number and diameter of these structures was 
comparable to those of human blastocysts30 (Fig. 1h, i).  To highlight the robustness of the 
protocol, all results were repeated with three established hPSC lines, RUES2, ESI-0017 and 
H9, upon their conversion to EPSCs (Fig. 1g, h). 
In order to understand if our system captured human-specific regulatory processes of cellular 
differentiation in early development, we first analysed hEPSCs before and after multicellular 
aggregate formation at different stages using quantitative RT-PCR (qRT-PCR) (Fig. 2a). We 
found that molecular markers known to be highly expressed in 2-to-8-cell blastomeres 
including ZSCAN4, THAP11 and NR5A210,26,31 were highly expressed in hEPSCs before 
aggregation, indicating the potential capacity of these cells to develop into various cell types 
(Fig. 2a). As expected, upon multicellular aggregate formation these markers became 
downregulated, suggesting early embryo-like cellular differentiation (Fig. 2a). Previous studies 
have demonstrated that the first lineage segregation event begins with compaction and cell 
polarisation in the mouse embryo at the 8-cell stage32-34. This process remains unclear in 
human early embryogenesis and only recently have studies begun to shed light on these 
events35,36. Hence, we utilised our platform to analyse the establishment and dynamics of 
compaction and cell polarisation at the early time-points of multicellular aggregate formation. 
The assembly of intercellular junctions is characterised by the formation of baso-lateral 
expression of E-CADHERIN, suggesting that the compaction events are recapitulated in this 
in vitro system within the first 24h of cell aggregation (Fig. 2b). We also found distinct apical 
enrichment of F-ACTIN (Fig. 2b), with PARD6 enrichment at the apical surface within the first 
48h of cell aggregation (Fig. 2b) indicative of cell polarisation. Next, we analysed 
spatiotemporal expression of the transcription factor GATA3, known as the earliest marker of 
TE specification in human embryogenesis. GATA3 was localised in the nucleus within both 
polarised and non-polarised cells at day 2 and day 3 of 3D culture, although the intensity of 
nuclear GATA3 staining was significantly higher in polarised cells, as judged by apical 
enrichment of PARD6 (Fig. 2c, d). These results correlated with natural human embryos at 
the morula stage36 (Fig. 2e). We have recently shown that the PLC-Protein Kinase C (PKC) 
pathway controls cellular polarisation at early stages of human development36. Of note, when 
U73122 (a selective PLC inhibitor) was applied at 2 μM and 3 μM in hEPSC 3D cultures, there 
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was significant reduction of the nuclear GATA3 signal intensity (Fig. 2d, Extended Data Fig. 
3a). This correlated with a decrease in the apical enrichment of PARD6 upon U73122 
treatment in 3D culture (Fig. 2f, Extended Data Fig. 3b). Finally, we confirmed the 
relationship between polarisation and outer cell commitment by using siRNA transfection to 
knock-down (KD) PLCB1 in order to deplete PLC activity36 in cells during 3D aggregation (Fig. 
2g). Again, this revealed a significant reduction in both PARD6 and GATA3 expression in 
hEPSC aggregates at day 3 (Fig. 2f-g, Extended Data 3c). In accord with recent findings in 
the human embryo36, our results further support the role of the acquisition of apicobasal 
polarity in promoting the expression and nuclear localisation of GATA3 to drive TE 
specification in early human development. 
We next sought to investigate the formation of blastocyst lineages upon cavitation of hEPSC-
derived structures from day 4 onwards. We first used qRT-PCR to examine the expression 
level of core transcription factors responsible for establishing the human blastocyst lineage 
identity (Fig. 3a). This revealed that genes involved in TE specification, including PLAC8, 
CDX2, KRT8 and KTR18, were strongly induced upon formation of cystic structures although 
GATA3 showed only a marginal increase compared to other molecular determinants of TE 
identity (Fig. 3a). As expected, crucial transcription factors required for pluripotent Epi 
specification, including NANOG and POU5F1, showed similar levels of expression in cystic 
structures as in hEPSCs cultured in 2D whereas KLF4 was significantly upregulated in the 
cystic structures (Fig. 3a). Finally, we found that the expression of the core Hypo lineage 
determinant genes, PDGFRA and GATA6, was highly enriched in cystic structures although 
SOX17 did not follow this trend (Fig. 3a). In order to confirm these results spatially and on a 
protein level, we performed immunofluorescence analysis with well-known lineage markers. 
In accord with the qRT-PCR results, we observed enrichment for KRT18 in the outside TE-
like layer, and expression of OCT4/SOX17 in the Epi/Hypo-like inner compartment (Fig. 3b). 
We further confirmed the Epi/Hypo-like lineage specification with a second set of markers, 
SOX2/FOXA213 (Fig. 3c). At day 4, some structures displayed constitutive expression of 
GATA3 in the outer cell layer while maintaining expression of the hPSC/Epi marker OCT4  
(10/23 structures scored) (Fig. 3d). At later time-points in culture (D6), some structures 
maintained GATA3 expression in the TE-like outside layer, although this enrichment became 
mostly cytosolic rather than nuclear (53/135 structures scored) (Fig. 3e). Such late-structures 
also showed poor expression of E-CADHERIN at day 6 (Fig. 3e). This likely indicates a 
deficiency in junction assembly during the late cavitation process and may explain the 
compromised expression of some TE-specific markers as in vitro development progresses. 
WNT3A supplementation is suggested to promote cavitation and thus TE-like lineage identity 
in in vitro mouse blastoid formation7, which correlates with canonical WNT expression in the 
TE lineage during mouse blastocyst development37. When we tested this possibility in our 
human platform, we found that WNT3A addition to the culture media did not make a significant 
difference in yield of cavitated structures at day 6 (Fig. 3f). This suggested that WNT3A 
functions differently in human cells/development than in mouse, supporting previous 
claims5,38. Taken together, we conclude that although the transcriptional machinery for 
blastocyst lineage programming is robustly initiated in hEPSCs, a continuum between distinct 
cell fates then develops, suggesting a failure in full trans-differentiation. 
We next tested the developmental capacity of these hEPSC-derived blastocyst-like structures 
to develop beyond implantation stages by culturing them in our previously established human 
embryo in vitro culture (IVC) platform15 (Fig. 4a). Within 24h in IVC, the blastocyst-like 
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structures reorganised into post-implantation-like disk-shaped structures, 60% of which had a 
SOX2 positive Epi-like inner compartment surrounded by a KRT18 and GATA3 positive extra-
embryonic-like compartment (Fig. 4b-d) with some structures also specifying FOXA2-
expressing Hypo-like cells (Fig. 4c). Significantly, we found that within 24h in IVC, SOX2 
positive cells in the Epi-like inner compartment became radially organised around a small 
central lumen (Fig. 4d). The formation of a small lumen was confirmed by PODXL expression 
(Fig. 4e). This demonstrates that this hEPSC-based system can undertake one of the 
hallmarks of human Epi lineage transformation at implantation, namely the acquisition of a 
polarised epithelium and the formation of a lumen, the prospective amniotic cavity14-16. This 
strongly suggests that this hEPSC-derived system is undertaking the cell rearrangements that 
characterize the initiation of post-implantation human morphogenesis. 
The restricted ability of TE lineage specification in blastocyst-like structures generated solely 
from hEPSCs led us to question whether these cells possess the capacity to fully generate 
the TE lineage in addition to Epi and Hypo commitment. We were recently able to correct a 
similar shortcoming in mouse blastoids by combining EPSCs with TSCs3.  As a recent study 
has showed it possible to derive human TSCs from first trimester human placental samples 
and blastocysts27, this led us to test whether such TSCs could participate alongside hEPSCs 
to build human blastoids (Extended Data Fig. 4a).  To this end, we first allowed hEPSCs to 
aggregate for 24h after which we added hTSCs3. The first 24h demonstrated the increased 
potential to generate both embryonic Epi-like and extraembryonic Hypo-like lineages in the 
EP condition compared to the conventional Rset condition (Extended Data 4b). Within 4 days 
of co-culture, we observed the formation of cystic structures having internal acentric hEPSC 
compartments. We also observed robust expression of blastocyst lineage markers, including 
GATA3, SOX2 and SOX17 (Extended Data Fig. 4c). Nevertheless, it appeared that these 
structures struggled to form a cohesive epithelium and displayed not one but multiple cavities 
(Extended Data Fig. 4c). Given that these hTSCs are reported to be most similar to villous 
cytotrophoblasts27, it seemed from our findings that these hTSCs may be more conducive to 
post- rather than pre-implantation development. We therefore tested recent conversion 
protocols described to transform hPSCs into putative human trophectoderm stem cells 
(hTESCs)39 (Extended Data Fig. 4d) that have been suggested to more closely resemble the 
pre-implantation TE lineage. However, we observed that these hTESCs showed little to no 
TE-specific marker expression, signifying an inability to maintain lineage identity upon co-
culture (Extended Data Fig. 4e). Thus, future work will be required to generate human TSC 
lines having the ability to recapitulate pre-implantation development in order to enhance this 
system further. 
In summary, the hEPSCs we describe here show multi-directional, enhanced developmental 
potency enabling them to develop the morphology of human blastocysts and peri-implantation 
stages and, exhibit many of the molecular features of cleavage stage pre-implantation 
embryos.  However, these cells are not the equivalent of totipotent blastomeres as although 
they appear able to specify Epi and Hypo cells, TE is only partially specified. This may reflect 
distinct molecular trajectories and an intermediate state adopted by these cells that lead to the 
generation of improperly differentiated cells observed in this study. Nevertheless, these cells 
successfully generate multicellular structures that are patterned similarly to the early human 
embryos. Thus, they offer the potential to be harnessed into a fully functional embryo-like 
platform in vitro. Collectively, the hEPSCs-based system we describe here recapitulates key 
features of natural human development from embryonic day 3 to day 9/10. It thus represents 
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a significant step towards developing an in vitro model that captures the dynamics of 
spatiotemporal pre/peri-implantation development in a 3D context. We anticipate that this 
system will lead to a variety of future applications and will be pivotal in unravelling many of the 
enigmas of human developmental regulation. 
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Figure 1. A 3D system to mimic early human embryogenesis from hEPSCs. A. Scheme 
for natural human pre/peri-implantation embryo development. B. A representative dome-
shaped naïve pluripotent hEPSC colony in 2D culture. C. Left: Schematic of an AggreWell 
and aggregation protocol to mimic early human development solely with hEPSCs. Right: 
Representative examples of cystic structures generated from a typical experiment after 4 days 
demonstrate three lineages, resembling blastocyst stage natural embryo. Lineage markers: 
SOX2, yellow (Epi-like); GATA3, magenta (TE-like), and SOX17, cyan (Hypo-like). n=10 
experiments.  D. Representative phase-contrast images of hEPSC multicellular aggregates in 
AggreWell at the indicated time points during 3D culture. E. Phase-contrast images of human 
blastocyst-like structures at D6. (top) and human blastocysts at D6 (bottom) F. A 
representative cystic structure generated from RUES2:SOX2-GFP reporter hEPSC line. G. A 
representative structure immunostained for SOX2 in magenta, KRT18 in yellow to label Epi-
like inner compartment and TE-like outside epithelium, respectively. DAPI is shown in blue. 
Maximum projection image is shown on the right. n=50 structures, 3 experiments. H. 
Quantification for cell numbers in individual cystic structures generated from three established 
hEPSC lines, ESI0017 (n=11), RUES2 (n=18) and H9 (n=13). I. Measurements of axial 
diameters in cystic structures from ESI0017 (n=11), RUES2 (n=18) and H9 (n=13). Illustration 
on right shows the two axes measured. All scale bars in the figure indicate 20 um. 
 
Figure 2. Recapitulation of key pre-Implantation developmental processes. A. Bulk qRT-
PCR analysis of genes ZCSAN4, THAP11, NR52A in EPSCs in 2D, and multicellular 
aggregates at day 4, 5, 6 formed in 3D represented as a heatmap of global Ct to GAPDH. 
20 multicellular cystic structures were pooled per group from 3D culture and a minimum of 
10K hEPSCs were collected from the 2D culture. B. Immunostaining of hEPSC aggregates at 
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22h for PARD6 (grey), F-ACTIN (red) and E-CADHERIN (cyan). n=300 aggregates, 3 
experiments. C. Quantification of GATA3 expression in cells with or without PARD6 apical 
enrichment observed in cells within Day 2 and Day 3 of multicellular aggregates. All 
measurements normalized to DAPI. Student’s t-test; p<0.05; 3 experiments. Error bars 
represent S.E.M. D. Immunostaining of control and U73122-treated hEPSC aggregates at 48h 
for PARD6 (green) and GATA3 (magenta). n=300 aggregates, 3 experiments. E. A 
representative natural human embryo at morula stage (D4) stained for PARD6 (green), F-
ACTIN (red), GATA3 (magenta). White arrowheads indicate apical PARD6 enrichment in the 
polarised cells with nuclear GATA3 expression. DAPI is shown in blue. F. Apical enrichment 
quantification of F-ACTIN and PARD6b at 48h in multicellular structures with or without 
addition of PLC inhibitor (U73122). Control groups received no inhibitor, while the two 
experimental groups were treated with either 2uM or 3uM U73122. Each dot represents one 
analysed cell. *p<0.05, Kruskal-Wallis test with a multiple comparisons test. Data is shown as 
mean S.E.M. n= 3 experiments. Also see Extended Data Figure 3b. G.  Left: Quantification of 
Pard6b apical enrichment at 48h and 72h in structures treated with either control siRNA or 
PLCB1 siRNA. Each dot represents one analysed cell. *p<0.05, Student’s t-test. Data is shown 
as mean S.E.M. n= 3 experiments. Right: Immunostaining of GATA3 (magenta) and PARD6 
(green) in structures treated with either control siRNA (top) or PLCB1 siRNA (bottom). DAPI 
is shown in blue. All scale bars in the figure indicate 20 um. 
Figure 3. Specification of blastocyst lineages. A. Bulk qRT-PCR analysis of blastocyst 
lineage marker genes in EPSCs in 2D, and multicellular aggregates at day 4, 5, 6 formed in 
3D represented as a heatmap of global Ct to GAPDH. 20 cystic structures were pooled per 
group from 3D culture and a minimum of 10K hEPSCs were collected from the 2D culture. B. 
Immunofluorescence staining of blastocyst-like structures generated from hEPSCs at day 5 
for OCT4 (green), KRT18 (white) and SOX17 (red). Zoom image on the right shows TE-like 
cells with KRT18 expression. DAPI is shown in blue. n= 30 structures, 3 experiments. C. A 
representative blastocyst-like structures generated from hEPSCs at day 5 stained for SOX2 
(green) and FOXA2 (red) to reveal Epi/Hypo-like inner compartment (zoom on the right). 
Image presented as maximum projection. n=20 structures, 2 experiments. D. 
Immunofluorescence staining of blastocyst-like structures generated from hEPSCs at day 4 
for OCT4 (green) and GATA3 (red). DAPI is shown in blue. n= 10/23 structures, 2 
experiments. E. Left: Immunofluorescence staining of GATA3 (green) and E-CADHERIN 
(magenta) in a representative blastocyst-like structure at day 6. Right: Quantification shows 
frequency of structures at day 6 of 3D culture showing Gata3 nuclear expression (57.03%, 
77/135 structures scored); Gata3 cytoplasmic expression (39.25%, 53/135 structures scored); 
no detectable Gata3 expression (3.70%, 5/135 structures scored). F. Quantification shows 
frequency of cavitated structures in control and WNT3A-supplemented culture. WNT3A is 
applied in either at 25 or 50 ng/mL concentration. ns, not significant. All scale bars in the figure 
indicate 20 um. 
 
Figure 4. hEPSC-derived cystic structures cultured in IVC demonstrate post-
implantation-like remodelling. A.  Illustration detailing the process of in vitro structure 
formation in three steps: hEPSC aggregation, self-organisation into blastocyst-like cystic 
structures, and post-implantation remodelling in IVC media (see Methods).  Below are phase-
contrast images showing a representative structure at each of these steps.  B. Left: Maximum 
projection of a representative post-implantation-like structure immunostained for GATA3 
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(cyan) to reveal extra-embryonic-like and SOX2 (yellow) for embryonic-like compartments. 
Right: quantification shows frequency of structures cultured in IVC media for 24h that showed 
SOX2+ inner compartment (60.4%, light grey), no inner compartment (38.4%, dark grey), or 
no development (1.2%, black). n = 260 structures scored in 3 experiments. C. Immunostaining 
showing the expression of TFAP2C (red), an extra-embryonic TE-derivative lineage marker, 
and FOXA2 (yellow), a Hypo marker, in a post-implantation-like structure cultured in IVC for 
24h.  Zoomed image on the right shows FOXA2 expressing Hypo-like cells (arrowheads). 
Yellow dashed-lines demarcates Epi-like inner compartment. D. Immunostaining of post-
implantation-like structure cultured in IVC media for 24h. The top panels show a mid-plane 
(left) and maximum projection (right) view of a representative structure with an Epi-like 
compartment marked by SOX2 expression (green), surrounded by extra-embryonic 
compartment marked by KRT18 (white). DAPI for nuclear staining is in blue. The bottom 
panels show inverted images for better clarity of DAPI signal for cell nucleus on the left and 
F-ACTIN+SOX2 double-staining on the right. The opening of a cavity within the Epi-like 
compartment (nuclear SOX2 expression) is marked by F-ACTIN. n= 20 structures, 3 
experiments.  E. Immunostaining showing the formation of a amniotic-like cavity, as marked 
by PODXL (magenta), within the ICM, marked by SOX2 (green), of an hEPSC-derived 
structure after 24h culture in IVC.  n= 20 structures, 3 experiments. DAPI staining is in blue.  
All scale bars in the figure indicate 20 um. 
 
Extended Data Figure 1. Characterisation of cellular and structural morphologies under 
2D and 3D culture conditions.  A.  DIC images showing varied colony morphology of hPSCs 
under EP culture conditions. The top image shows dome-shaped morphology, characteristic 
of pluripotent cells at the naïve state, while the bottom images show flat colonies, characteristic 
of cells in the primed state. B. DIC images of hEPSC-derived cystic structures grown for 5 
days with (top) and without (bottom) IVF media. Quantification on the right shows the 
frequency of cystic structure formation in each condition (+/- IVF). Student’s t-test; p<0.001; 3 
experiments. C. Comparison of hEPSC-derived blastocyst-like structures at day 6 (D6) of 3D 
culture to the natural human blastocyst at the same developmental time point. Quantification 
on the right shows the frequency of cystic structure formation under 20% O2 (Normoxia; grey 
circle) and 5% O2 (Hypoxia; white square) conditions. Student’s t-test; p<0.001; 3 experiments.  
All scale bars in the figure indicate 20 um. 
 
Extended Data Figure 2.  Screening of growth factors and inhibitors on hEPSC-derived 
structures. A.  Table outlining tested media conditions with and without specific growth 
factors and inhibitors (left), and observed features from each of these conditions (right).   B, 
C.  Images show failure of cell survival grown for 5 days without CHIR99021 (Chiron, condition 
2, C2) or Y-27632 (Y2; condition 3, C3), respectively.  D.  Immunostaining showing expression 
of TFAP2C (white), and GATA6 (magenta) in structures grown under condition 4 (C4) for 5 
days.  DAPI shows nuclear staining in blue. E.  Immunostaining showing expression of GATA3 
(red), and SOX2 (green) in structures grown under condition 5 (C5) for 5 days. DAPI shows 
nuclear staining in blue. F. Immunostaining for SOX2 (magenta), and KRT18 (yellow) in 
representative structure grown under condition 6 (C6) until Day 6. Images are shown in a 
single plane view (top left), maximum projection (top right), and as a montage panel of Z-stack 
slice 1-20. All scale bars in the figure indicate 20 um. 
 
Extended Data Figure 3.  Expression of nuclear GATA3 intensity upon PLC-Protein 
Kinase C (PKC) pathway suppression. A.  Quantification of nuclear GATA3 signal intensity 
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in control and experimental groups treated with either 2uM or 3uM of selective PKC inhibitor, 
U73122. All measurements normalized to DAPI. Each dot represents one analysed cell. 
*p<0.05, ANOVA with a multiple comparisons test. Data is shown as mean S.E.M. 3 
experiments. B. F. Apical enrichment quantification of F-ACTIN and PARD6b at 24, 48h and 
72h in multicellular structures with or without addition of PLC inhibitor (U73122). Control 
groups received no inhibitor, while the two experimental groups were treated with either 2uM 
or 3uM U73122. Each dot represents one analysed cell. *p<0.05, Kruskal-Wallis test with a 
multiple comparisons test. Data is shown as mean S.E.M. n= 3 experiments. C. Left: 
Quantification of PLCB1 knock-down efficiency in groups treated with either control siRNA or 
PLCB1 siRNA as determined by RT-PCR. Values were normalized against GAPDH. *p<0.001, 
Student’s t-test. n = 3 replicates. Right: Quantification of nuclear GATA3 signal intensity in 
groups treated with either Control siRNA or PLCB1 siRNA. All measurements normalized to 
DAPI. Each dot represents one analysed cell. *p<0.001, Student’s t-test.  
 
Extended Data Figure 4. Generation of blastocyst-like structures using hEPSCs and 
hTSCs. A. 2-step protocol for generating blastocyst-like structures from EPSCs combined 
with hTSCs. B. Aggregates co-expressing endogenous SOX2 (green) and SOX17 (red) after 
the first step (24h) of aggregation. SOX2 indicates naive pluripotent Epi-like cells; SOX17 
indicates extra-embryonic hypoblast-like cell formation. Quantification on the right shows 
structures scored as positive for hypoblast-like cell in conventional naïve Rset condition and 
EP condition. n = 100 aggregates per group. C. A representative structure generated from 
EPSCs combined with hTSCs stained for GATA3, SOX2 and SOX17. DIC image reveals the 
failure for cavitation. D. DIC image for a representative dome-shaped naïve human ESC 
colony in 2D culture (left) and the morphology after their conversion to human TESCs 
(hTESCs). E. Representative structure that generated from hEPSCs combined with hTESCs 
reveals the failure for TE-identity. SOX2 (green) for Epi-like, SOX17 (red) for Hypo-like, 





No statistical methods were used to predetermine sample size. The experiments were not 
randomized and the investigators were not blinded to allocation during experiments and 
outcome assessment. 
Ethics statement 
Stem cell-derived multicellular structures described in this study show no evidence of germ 
line patterning, thus they do not have human organismal form or potential. Additionally, all 
experiments were terminated by no later than day 8 in vitro. Our research was subject to 
review and approval from the Human Embryo and Stem Cell (HESC) Committee of California 
Institute of Technology, in compliance with the ISSCR 2016 guidelines. 
 
Human Cell lines 
The hPSC lines utilized in this study include: RUES2-RLG (kindly provided by Ali Brivanlou, 
The Rockefeller University, US), H9 (kindly provided by Juan Carlos Izpisua Belmonte, The 
Salk Institute, US) and ESI0017 (kindly provided by Juan Michael Elowitz, California Institute 
of Technology, US). Human TSCs were kindly provided by Hiroaki Okae and Takahiro Arima 
(Tohoku University Graduate School of Medicine, Japan). Each of these cell lines was tested 
negative for mycoplasma contamination, which was monitored on a bi-monthly basis 
(MycoScope™ PCR Mycoplasma Detection Kit, Genlantis).  
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Cell culture 
All hEPSC lines were maintained under 20% O2 and 5% CO2 at 37°C conditions on irradiated 
CF1 mouse embryonic fibroblasts (MEF) feeder cells.  hEPSCs were grown us ing ‘human 
Expanded Potential’ (hEP) medium consisting of DMEM/F12 (Thermo Fisher Scientific, 
11320-033), Neurobasal-A (Thermo Fisher Scientific, 21103-049), N2 supplement (Thermo 
Fisher Scientific, 17502-048), B27 supplement (Thermo Fisher Scientific, 12587-010), 1% 
GlutaMAX (Thermo Fisher Scientific, 35050-061), 1% nonessential amino acids (Thermo 
Fisher Scientific, 11140-050), 0.1 mM b-mercaptoethanol (Thermo Fisher Scientific, 31350-
010), penicillin-streptomycin (Thermo FisherScientific, 15140–122) and 5% knockout serum 
replacement (KSR, Thermo Fisher Scientific, A3181502). LCDMYI supplementation was 
added as indicated at the following concentrations: 10 ng ml−1 recombinant human LIF (L, 10 
ng ml−1; Peprotech, 300-05), CHIR99021 (C, 1 mM; Stem Cell Technologies), (S)-(+)-
Dimethindenemaleate (D, 1 mM; Tocris, 1425) and Minocycline hydrochloride (M, 2 mM; 
Santa Cruz Biotechnology, sc-203339), 1.  All hEPSCs were used before reaching P70 and 
cell cultures were examined by eye to monitor for spontaneous differentiation of colonies into 
mesenchymal-like cells.  
 
hTSCs were cultured on 6-well plates pre-coated with 5 mg/ml Col IV at 37C for at least one 
hour, as previously described in Okae et al27.  Cells were grown in ‘human Trophoblast stem 
cell’ (hTS) medium consisting of DMEM/F12 supplemented with 0.1 mM b-mercaptoethanol, 
0.2% FBS, 0.5% Penicillin-Streptomycin, 0.3% BSA (A8806-5G, Sigma-Aldrich), 1% ITS-X 
supplement (51500-056, Thermo Fisher Scientific), 1.5 mg/ml L-ascorbic acid (A4403, Sigma-
Aldrich), 50 ng/ml EGF (62253-63-8, Sigma-Aldrich), 2 mM CHIR99021, 0.5 mM, A83-01 
(72024, Stemcell Technologies), 1 mM SB431542 (Stem Cell Technologies), 0.8 mM VPA 
(Sigma-Aldrich) and 5 mM Y27632  hTESCs were grown on 6-well plates as described in 
Mischeler et al. 39  with some modifications.  Plates were pre-coated with coated with 3 µg/ml 
of vitronectin (07180, Stemcell Technologies) and 5mg/mL Col IV (C7521-5MG, Sigma-
Aldrich), instead of laminin 521 and cells were grown in TM4 media consisteing of the 
following: TeSR-E6 medium supplemented with CYM5541 (2 µM), A 83-01 (0.5 µM), FGF10 
(25ng/ml) and CHIR99021 (2 µM).   
 
Preparing and Plating Cell Suspensions for ‘‘AggreWell’’ Aggregation Experiments 
AggreWell 400 format plates were prepared following the manufacturer’s protocol. Briefly, 
wells were rinsed with the rinsing solution (Stem Cell Technologies), centrifuged for 5 min at 
2000g and incubated at room temperature in the tissue culture hood for 20 min. The wells 
were then washed with 2 ml of 1X PBS. After PBS removal, 500 ml of final culture medium 
(IVF-hEP-hTS, see below) was added to each well and the plate placed at 37C and 5% CO2 
until ready to use. 
 
Generation of multicellular aggregates in 3D 
To begin, hEPSCs were dissociated to single cells by incubation with Accutase (07920, Stem 
Cell Technologies) at 37°C for 3 min. Cells were collected and pelleted by centrifugation for 
4 min at 1000 rpm and resuspended in hEP-LCDMYI medium (described above). This cell 
suspension was pre-incubated at 37°C in an atmosphere of 5% CO2 on gelatinized tissue-
culture-grade plates for 30 min to remove inactive MEFs.  
 
Post incubation on gelatin plates, cells were counted using a haemocytometer and a total of 
7200 hEPSCs was added to 1mL of media composed of 50% IVF media (Continuous Single 
Culture-NX Complete (CSCM-NXC)) (90168, FUJIFILM), 25% hEP media, and 25% hTS 
media.  This media was also supplemented with CHIR99021 (2uM), Y27632 (5uM), BMP4 
(20ng/mL), FGF2 (40ng/mL), and A83-01 (2uM). Cell suspensions were added dropwise to 
the Aggrewells.  All wells without cells were filled with 1mL PBS to humidify the local 
atmosphere to minimize evaporation. The AggreWell plate was then centrifuged for 3 min at 
100g, and placed at 37°C under hypoxic conditions (5% CO2 and 5% O2). After 48h, media 
was removed from wells and replaced with fresh culture media as described above, although 
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FGF2 concentration was lowered to 20ng/mL and A83-01 was omitted. Cells were left to grow 
for an additional 48-72h until proper morphology was observed, at which point structures were 
fixed for immunostaining or transferred to IVC media (see below) for mimicking development 
beyond implantation stages. 
 
Criteria for selecting multicellular aggregates structures 
Following completion of any given aggregation experiment (from day 4 to 6), all cystic 
structures those clearly displaying a cavity were included in further analyses. Non-cavitated 
structures were excluded from downstream analyses. 
 
Co-culture of hEPSCs with hTSCs/hTESCs  
To perform two-step aggregation experiments, hEPSCs were first seeded as described above 
hEP-LCDMYI media. After a 24h period of aggregation, hTSC or hTESC colonies were 
dissociated to single cells, and counted using a haemocytometer. For hTSC experiments, 50% 
hEP media and 50% hTS media is used as described above. For hTESC experiments, hTS 
media was replaced with TeSR-E6, all other factors remained the same. A total of 16,800 
hTSCs/hTESCs were added per well and the plate was placed at 37°C, 5% CO2 and 5% O2. 
 
In Vitro Culture of hEPSC blastocyst-like structures beyond implantation 
To prepare plate for in vitro culture, 150uL of modified IVC1 (mIVC1) media was added to 
each well of a 96-well ultra-low attachment U-shaped plate (7007, Costar). mIVC1 media 
consisted of the following: Advanced DMEM/F12 (12634-010; Thermo Fischer Scientific; 
Waltham, US) supplemented with 20% (vol/vol) heat-inactivated FBS (16141079, Thermo 
Fisher Scientific), 2mM GlutaMAX, penicillin (25 units/ml)/Streptomycin (25 μg/ml), 1X ITS-X 
(10 mg/L insulin , 5.5 mg/L transferrin, 0.0067 mg/L sodium selenite, 2 mg/L etholamine; 
51500-056; Thermo Fisher Scientific; Waltham, US), 8 nM β-estradiol (E8875; Sigma-Aldrich; 
St. Louis, US), 200 ng/ml progesterone (P0130; Sigma-Aldrich; St. Louis, US), 25 μM N-
acetyl-L-cysteine (A7250; Sigma-Aldrich; St. Louis, US), 17nm IGF1, 20ng/mL FGF2 (Gibco),  
FGF4 (25 ng/mL; R&D Systems, 5846-F4) and heparin (1 mg ml-1; Sigma, H3149). 
 
Immunofluorescence Staining 
Stem cell-derived structures were fixed in 4% paraformaldehyde (Electron Microscopy 
Sciences, 15710) for 20 min at room temperature, and then washed twice in PBT [phosphate-
buffered saline (PBS) plus 0.05% Tween-20].  Structures were permeabilized for 30 min at 
room temperature in PBS containing 0.3% Triton-X-100 and 0.1% glycine. Primary antibody 
incubation was performed overnight at 4°C in blocking buffer [PBS containing 10% fetal bovine 
serum (FBS), 1% Tween-20]. The following day, embryos were washed twice in PBT, then 
incubated overnight at 4°C with secondary antibody (1:500) in blocking buffer. Structures were 
washed twice in PBT buffer and then transferred to PBT drops in oil-filled optical plates before 
confocal imaging. The antibodies used are given in Supplementary Data Table 1.  
For human embryo images shown in Figure 2e, embryos were fixed in IVIRMA Valencia, 
washed twice in a PBS solution containing 0.1% Tween-20 (Sigma, cat. no. P9416) and 
immediately placed into a 0.5 ml PCR tube within an oil-PBS-oil interphase. Tubes were stored 
at 4ºC were shipped to the University of Cambridge for immunofluorescence.  
 
Image Data Acquisition, Processing, and Quantification 
Fluorescence images were acquired with an inverted Leica SP8 confocal microscope (Leica 
Microsystems), using a Leica Fluotar VISIR 0.95 NA 25x objective. Fluorophores were excited 
with a 405-nm diode laser (DAPI), a 488-nm argon laser (GFP), a 543-nm HeNe laser (Alexa 
Fluor-543/555) and a 633-nm HeNe laser (Alexa Fluor-633/647). Images were acquired with 
0.5–1.2 mm z-separation. Raw data were processed using open-source image analysis 
software ‘‘Fiji’’ software and assembled in Photoshop CC 2019 (Adobe). Digital quantifications 
and immunofluorescence signal intensity graphs were obtained using Fiji software. 
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Apical enrichment analysis: F-actin and PARD6 polarisation were measured in a single focal 
plane, by taking the middle plane of the aggregate. A freehand line of the width of 0.5μm was 
drawn along the cell-contact free surface (apical domain), or cell-contact (basal) area of the 
cell, signal intensity was obtained via the Region of Interest (ROI) function of Fiji. The 
apical/basal signal intensity ratio is calculated as: I(apical)/I(basal). A cell is defined as 
polarised when the ratio between the apical membrane and the cytoplasm signal intensity 
exceeds 1.5.  
GATA3 expression analysis: the nucleus of each cells is masked using the Region of Interest 
(ROI) tool of Fiji. The average signal intensity of the ROI is calculated and a cell is defined as 
GATA3 positive when the nucleus to cytoplasm signal intensity exceeds 1.5. 
 
siRNA-mediated knock-down in hEPSC-derived aggregates 
Transfections of siRNA were performed using Lipofectamine RNAi MAX (13778075, Thermo 
Fisher Scientific) according to the manufacturer's instructions. Upon seeding hEPSCs into 
AggreWells (as described above), Lipofectamine and siRNA (Qiagen, Hs_PLCB1_4, 
SI00115521; Qiagen, Hs_PLCB1_6, SI02781184; Qiagen, negative control siRNA, 1022076) 
against target genes with Opti-MEM (31985070, Gibco) is mixed and the mixture of either 
control siRNA or PLCB1 siRNA were evenly added into each well. Cell aggregates at 48h 
were collected to analyse the gene expression by qRT-PCR. 
 
Bulk qRT-PCR Analysis   
Total RNA was extracted with using Arcturus PicoPure™ RNA Isolation Kit (12204-01, Applied 
Biosystems) as per manufacturer’s instructions. QRT-PCR was performed with the Power 
SYBR Green RNA-to-CT 1-Step Kit (Life Technologies) and a Step One Plus Real-time PCR 
machine (Applied Biosystems). The amounts of mRNA were measured with SYBR Green 
PCR Master Mix (Ambion). Relative levels of transcript expression were assessed by the ∆∆Ct 
method, with Gapdh as an endogenous control. For qPCR primers used, see Supplementary 
Data Table 2. 
 
Statistics and Reproducibility 
Statistical tests were performed on GraphPad Prism 8.0 software. Where appropriate, 
Student’s t-tests (two groups) or analysis of variance (multiple groups) were performed. Figure 
legends indicate the number of independent experiments performed in each analysis. Unless 
otherwise noted, each experiment was performed at least two times. 
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Targeted	Protein Species Dilution Catalog	No. Vendor
PARD6 Rabbit 1:200 sc-166405 Santa	Cruz	Biotechnology
E-Cadherin	(Clone		
36)
Mouse 1:200 610182 BD	Biosciences
OCT3/4 Rabbit 1:200 Sc-9081 Santa	Cruz	Biotechnology
SOX2 Rabbit 1:200 D6D9 Cell	Signaling	Technologies
GATA3 Goat 1:200 AF2605 R&D	Systems
PODXL Mouse 1:20 MAB1658 R&D	Systems
SOX17 Goat 1:200 AF1924 R&D	Systems
FOXA2 Rabbit 1:200 D56D6 Cell	Signaling	Technologies




N/A 1:500 A12379 Thermo	Fisher	Scientific
TFAP2C Goat 1:200 AF5059 R&D	Systems
KRT18 Mouse 1:200 Ab668 Abcam
















Extended Data Table 1. List of primary antibodies.
Extended Data Table 2.  List of primers for RT-qPCR.
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